The Relationship Between Comorbidities and Microbiologic Findings in Patients with Acute Exacerbation of Chronic Obstructive Pulmonary Disease

References

• Wedzicha JA, Seemungal TA. COPD exacerbations: defining their cause and prevention. Lancet. 2007;370(9589):786–796. doi:10.1016/S0140-6736(07)61382-8
   PubMed Web of Science ®Google Scholar
• Niewoehner DE. The impact of severe exacerbations on quality of life and the clinical course of chronic obstructive pulmonary disease. Am J Med. 2006;119(10 Suppl 1):38–45. doi:10.1016/j.amjmed.2006.08.006
   PubMed Web of Science ®Google Scholar
• Spencer S, Calverley P, Burge PS, Jones PW. Impact of preventing exacerbations on deterioration of health status in COPD. Eur Respir J. 2004;23(5):698–702. doi:10.1183/09031936.04.00121404
   PubMed Web of Science ®Google Scholar
• Ramsey S, Sullivan S. The burden of illness and economic evaluation for COPD. Eur Respir J. 2003;21(41 suppl):29s–35s. doi:10.1183/09031936.03.00078203
   Web of Science ®Google Scholar
• Ford ES, Murphy LB, Khavjou O, Giles WH, Holt JB, Croft JB. Total and state-specific medical and absenteeism costs of COPD among adults aged ≥18 years in the United States for 2010 and projections through 2020. Chest. 2015;147(1):31–45. doi:10.1378/chest.14-0972
   PubMed Web of Science ®Google Scholar
• Sin DD, Anthonisen NR, Soriano JB, Agusti AG. Mortality in COPD: role of comorbidities. Eur Respir J. 2006;28(6):1245–1257. doi:10.1183/09031936.00133805
   PubMed Web of Science ®Google Scholar
• Almagro P, Cabrera FJ, Diez J, et al. Comorbidities and short-term prognosis in patients hospitalized for acute exacerbation of COPD: the EPOC en Servicios de medicina interna (ESMI) study. Chest. 2012;142(5):1126–1133. doi:10.1378/chest.11-2413
   PubMed Web of Science ®Google Scholar
• Terzano C, Colamesta V, Unim B, et al. Chronic obstructive pulmonary disease (COPD) exacerbation: impact of comorbidities on length and costs during hospitalization. Eur Rev Med Pharmacol Sci. 2017;21(16):3680–3689.
   PubMed Web of Science ®Google Scholar
• Spece LJ, Epler EM, Donovan LM, et al. Role of comorbidities in treatment and outcomes after chronic obstructive pulmonary disease exacerbations. Ann Am Thorac Soc. 2018;15(9):1033–1038. doi:10.1513/AnnalsATS.201804-255OC
   PubMed Web of Science ®Google Scholar
• Sethi S, Murphy TF. Infection in the pathogenesis and course of chronic obstructive pulmonary disease. N Engl J Med. 2008;359(22):2355–2365. doi:10.1056/NEJMra0800353
   PubMed Web of Science ®Google Scholar
• Sapey E, Stockley RA. COPD exacerbations· 2: aetiology. Thorax. 2006;61(3):250–258. doi:10.1136/thx.2005.041822
   PubMed Web of Science ®Google Scholar
• Papi A, Bellettato CM, Braccioni F, et al. Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations. Am J Respir Crit Care Med. 2006;173(10):1114–1121. doi:10.1164/rccm.200506-859OC
   PubMed Web of Science ®Google Scholar
• Choi J, Oh JY, Lee YS, et al. Bacterial and viral identification rate in acute exacerbation of chronic obstructive pulmonary disease in Korea. Yonsei Med J. 2019;60(2):216–222. doi:10.3349/ymj.2019.60.2.216
   PubMed Web of Science ®Google Scholar
• Lee MS, Oh JY, Kang CI, et al. Guideline for antibiotic use in adults with community-acquired pneumonia. Infect Chemother. 2018;50(2):160–198. doi:10.3947/ic.2018.50.2.160
   PubMed Web of Science ®Google Scholar
• Lenferink A, van der Palen J, van der Valk P, et al. Exacerbation action plans for patients with COPD and comorbidities: a randomised controlled trial. Eur Respir J. 2019;54(5):1802134. doi:10.1183/13993003.02134-2018
   PubMed Web of Science ®Google Scholar
• Vanfleteren LE, Spruit MA, Groenen M, et al. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2013;187(7):728–735. doi:10.1164/rccm.201209-1665OC
   PubMed Web of Science ®Google Scholar
• Hillas G, Perlikos F, Tsiligianni I, Tzanakis N. Managing comorbidities in COPD. Int J Chron Obstruct Pulmon Dis. 2015;10:95–109. doi:10.2147/COPD.S54473
   PubMed Web of Science ®Google Scholar
• Fumagalli G, Fabiani F, Forte S, et al. INDACO project: COPD and link between comorbidities, lung function and inhalation therapy. Multidiscip Respir Med. 2015;10(1):4. doi:10.1186/2049-6958-10-4
   PubMedGoogle Scholar
• Almagro P, Lopez Garcia F, Cabrera FJ, et al. Comorbidity and gender-related differences in patients hospitalized for COPD. The ECCO study. Respir Med. 2010;104(2):253–259. doi:10.1016/j.rmed.2009.09.019
   PubMed Web of Science ®Google Scholar
• Andreas S, Testa M, Boyer L, et al. Non-typeable Haemophilus influenzae–Moraxella catarrhalis vaccine for the prevention of exacerbations in chronic obstructive pulmonary disease: a multicentre, randomised, placebo-controlled, observer-blinded, proof-of-concept, phase 2b trial. Lancet Respir Med. 2022. doi:10.1016/S2213-2600(21)00502-6
   PubMed Web of Science ®Google Scholar
• Eklof J, Sorensen R, Ingebrigtsen TS, et al. Pseudomonas aeruginosa and risk of death and exacerbations in patients with chronic obstructive pulmonary disease: an observational cohort study of 22 053 patients. Clin Microbiol Infect. 2020;26(2):227–234. doi:10.1016/j.cmi.2019.06.011
   PubMed Web of Science ®Google Scholar
• Almagro P, Salvado M, Garcia-Vidal C, et al. Pseudomonas aeruginosa and mortality after hospital admission for chronic obstructive pulmonary disease. Respiration. 2012;84(1):36–43. doi:10.1159/000331224
   PubMed Web of Science ®Google Scholar
• Polverino E, Cilloniz C, Menendez R, et al. Microbiology and outcomes of community acquired pneumonia in non cystic-fibrosis bronchiectasis patients. J Infect. 2015;71(1):28–36. doi:10.1016/j.jinf.2015.03.009
   PubMed Web of Science ®Google Scholar
• Sanchez-Muñoz G, López-de-andrés A, Hernández-Barrera V, et al. Hospitalizations for community-acquired and non-ventilator-associated hospital-acquired pneumonia in Spain: influence of the presence of bronchiectasis. A retrospective database study. J Clin Med. 2020;9(8):2339. doi:10.3390/jcm9082339
   PubMed Web of Science ®Google Scholar
• Dicker AJ, Lonergan M, Keir HR, et al. The sputum microbiome and clinical outcomes in patients with bronchiectasis: a prospective observational study. Lancet Respir Med. 2021;9(8):885–896. doi:10.1016/S2213-2600(20)30557-9
   PubMed Web of Science ®Google Scholar
• Jin J, Li S, Yu W, Liu X, Sun Y. Emphysema and bronchiectasis in COPD patients with previous pulmonary tuberculosis: computed tomography features and clinical implications. Int J Chron Obstruct Pulmon Dis. 2018;13:375–384. doi:10.2147/COPD.S152447
   PubMed Web of Science ®Google Scholar
• Jin J, Yu W, Li S, Lu L, Liu X, Sun Y. Factors associated with bronchiectasis in patients with moderate-severe chronic obstructive pulmonary disease. Medicine. 2016;95(29):e4219. doi:10.1097/MD.0000000000004219
   PubMed Web of Science ®Google Scholar
• Byrne AL, Marais BJ, Mitnick CD, Lecca L, Marks GB. Tuberculosis and chronic respiratory disease: a systematic review. Int J Infect Dis. 2015;32:138–146. doi:10.1016/j.ijid.2014.12.016
   PubMed Web of Science ®Google Scholar
• Okimoto N, Hayashi T, Ishiga M, et al. Clinical features of Escherichia coli pneumonia. J Infect Chemother. 2010;16(3):216–218. doi:10.1007/s10156-010-0034-Z
   PubMed Web of Science ®Google Scholar
• Schneer S, Khoury J, Adir Y, et al. Clinical characteristics and outcomes of patients with Escherichia coli in airway samples. Clin Respir J. 2020;14(3):205–213. doi:10.1111/crj.13116
   PubMed Web of Science ®Google Scholar
• Miravitlles M, Espinosa C, Fernández-Laso E, Martos JA, Maldonado JA, Gallego M. Relationship between bacterial flora in sputum and functional impairment in patients with acute exacerbations of COPD. Chest. 1999;116(1):40–46. doi:10.1378/chest.116.1.40
   PubMed Web of Science ®Google Scholar
• Eller J, Ede A, Schaberg T, Niederman MS, Mauch H, Lode H. Infective exacerbations of chronic bronchitis: relation between bacteriologic etiology and lung function. Chest. 1998;113(6):1542–1548. doi:10.1378/chest.113.6.1542
   PubMed Web of Science ®Google Scholar
• Mohan A, Chandra S, Agarwal D, et al. Prevalence of viral infection detected by PCR and RT-PCR in patients with acute exacerbation of COPD: a systematic review. Respirology. 2010;15(3):536–542. doi:10.1111/j.1440-1843.2010.01722.x
   PubMed Web of Science ®Google Scholar